Sorrento Therapeutics, Inc. financial statements
Sorrento Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2022
| Revenue | USD 62.84M | EODHD |
| Net income | −USD 559.33M | EODHD |
| Cash and equivalents | USD 23.63M | EODHD |
| Total debt | USD 134.5M | EODHD |
Sorrento Therapeutics, Inc. financials on 6ix · Sorrento Therapeutics, Inc. on 6ix